Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Wnt signaling is important for development and cell regulation but can cause diseases like cancer when not working properly.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Finasteride may cause kidney damage.

Ayurveda, using herbs like ginger, garlic, and turmeric, can reduce chemo-radiotherapy side effects in cancer patients.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Suppressing very long chain fatty acids is linked to skin cancer.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

There might be a link between male pattern baldness and a higher risk of prostate cancer and testicular cancer.

Dutasteride may help treat prostate cancer by causing cancer cells to shrink and die.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Prostate cancer risk is not linked to blood testosterone levels.

CEC levels may be a useful marker for predicting prostate cancer progression.

CT scans can find serious prostate cancer even when PSA levels are low.

A dog's hair loss was caused by a hormone-secreting testicular tumor.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

TURP specimens should be checked for various tumors, not just common prostate issues.

The conclusion is that there might be a link between certain types of baldness and prostate cancer, which could be due to shared hormonal pathways.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.